Cita APA

Makhlin, I., Salinas, R. D., Zhang, D., Jacob, F., Ming, G., Song, H., . . . Bagley, S. J. (2019). Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma. CNS Oncol.

Citación estilo Chicago

Makhlin, Igor, et al. "Clinical Activity of the EGFR Tyrosine Kinase Inhibitor Osimertinib in EGFR-mutant Glioblastoma." CNS Oncol 2019.

Cita MLA

Makhlin, Igor, et al. "Clinical Activity of the EGFR Tyrosine Kinase Inhibitor Osimertinib in EGFR-mutant Glioblastoma." CNS Oncol 2019.